Congenital Heart Disease (CHD) remains one of the most significant challenges in pediatric medicine globally, and in Indonesia, it has emerged as a critical public health priority. While the precise etiology of CHD—structural abnormalities of the heart that develop before birth—often remains medically elusive, the identification of modifiable risk factors offers a vital pathway for prevention. Medical experts emphasize that while not every case can be predicted, the implementation of rigorous prenatal care, targeted vaccinations, and early diagnostic screenings can drastically alter the trajectory for thousands of infants born with these conditions each year.
The Indonesian Pediatric Society (IDAI) has recently intensified its efforts to educate the public on the complexities of CHD. Dr. Rizky Adriansyah, a pediatric specialist and Chairman of the Cardiology Coordination Unit at IDAI, underscores that although the exact cause of a specific heart defect may not always be identified, several high-risk factors during pregnancy are well-documented in contemporary medical literature. By addressing these factors, healthcare providers and expectant mothers can work together to reduce the incidence of heart-related birth defects.
Understanding the Risk Landscape During Pregnancy
The development of the fetal heart occurs very early in the first trimester, often before a woman even realizes she is pregnant. This window of vulnerability is where external factors can interfere with the intricate process of cardiac morphogenesis. Dr. Rizky points to three primary risk factors that have gained significant attention in recent clinical discussions: viral infections, nutritional deficiencies, and the consumption of certain medications.
Rubella infection, also known as German measles, is a primary concern. When a pregnant woman contracts the Rubella virus, it can cross the placental barrier and cause Congenital Rubella Syndrome (CRS), which frequently results in multiple birth defects, including serious heart malformations. The second critical factor is the deficiency of folic acid. Folic acid is essential for DNA synthesis and cell growth; a lack of this nutrient has long been linked to neural tube defects, but recent data increasingly points to its necessity in proper heart valve and chamber formation.
Furthermore, the use of specific medications during pregnancy, particularly anti-seizure or anti-epileptic drugs, has been identified as a significant risk factor. These medications can interfere with the signaling pathways required for fetal heart development. While chronic conditions like epilepsy must be managed, medical experts urge women of childbearing age to consult with their physicians to adjust dosages or switch to safer alternatives before conceiving.
Interestingly, the discourse around CHD risk factors has evolved. While traditional warnings against smoking and alcohol consumption remain valid and essential, clinical observations in Indonesia show that many cases of CHD occur in children whose mothers did not smoke or drink. This reality highlights the complexity of the condition and the need for a multifaceted approach to prenatal health that goes beyond avoiding "bad habits" to actively pursuing protective measures like vaccination and supplementation.
The Burden of CHD on Indonesian Neonatal Health
The statistical reality of CHD in Indonesia is sobering. According to national data from 2017, CHD is the second leading cause of death during the neonatal period (the first 28 days of life), accounting for approximately 17 percent of all neonatal fatalities. It is surpassed only by complications related to prematurity. This high mortality rate underscores the urgency of improving both preventive measures and the quality of postnatal cardiac care.
On a global scale, the World Health Organization (WHO) estimates that approximately one in every 100 newborns suffers from some form of CHD. Of these, approximately 25 percent are classified as "critical" Congenital Heart Disease (CCHD). Critical cases require surgical intervention or catheter-based procedures within the first year—and often the first days—of life to ensure survival. In the context of Indonesia’s birth rate, this translates to thousands of critical cases every year, many of which remain undiagnosed until it is too late.
Despite the high prevalence, the treatment gap in Indonesia remains wide. Dr. Rizky notes that currently, less than 50 percent of CHD cases in the country receive the necessary medical or surgical intervention. This discrepancy is driven by several systemic factors, including a lack of specialized cardiac centers outside of major metropolitan hubs, a shortage of pediatric cardiologists and cardiovascular surgeons, and a general lack of public awareness regarding the early signs of heart distress in infants.
Early Detection: The Role of Pulse Oximetry and Clinical Screening
The window for successfully treating critical CHD is narrow. Many infants with heart defects appear healthy immediately after birth, only to deteriorate rapidly as the ductus arteriosus (a temporary blood vessel in the fetal heart) closes in the days following delivery. Therefore, early detection is the cornerstone of reducing neonatal mortality.
One of the most significant advancements in bedside screening is the use of pulse oximetry. This non-invasive, painless, and cost-effective test measures the oxygen saturation in a newborn’s blood. By placing sensors on the infant’s right hand and either foot, healthcare providers can detect subtle differences in oxygen levels that may indicate an underlying heart defect. Dr. Rizky emphasizes that this method is highly sensitive and can be performed in less than five minutes by nurses or midwives in primary health centers.
In addition to oximetry, the traditional use of the stethoscope remains a vital tool. The presence of a heart murmur—an unusual sound heard between heartbeats—can be an early indicator of structural issues. However, not all murmurs are pathological, and not all heart defects produce a murmur, which is why clinical suspicion must be high. If a murmur is detected or if oxygen levels are sub-optimal, the gold standard for diagnosis is an echocardiogram (an ultrasound of the heart), which allows specialists to visualize the heart’s structure and blood flow in real-time.
Symptoms and Clinical Indicators in Infants
For parents and primary caregivers, recognizing the clinical symptoms of CHD is essential, especially in regions where advanced screening may not be routine. One of the most common signs of a heart defect in an infant is poor weight gain, often referred to as "failure to thrive." Because the heart has to work significantly harder to pump blood, the infant burns more calories than they can consume, and the exhaustion from the effort of feeding often leads to inadequate intake.
Other symptoms include:
- Cyanosis: A bluish tint to the lips, tongue, or fingernails, indicating low oxygen levels.
- Tachypnea: Rapid or labored breathing, even when the baby is at rest.
- Diaphoresis: Excessive sweating, particularly during feeding.
- Fatigue: The infant may become tired very quickly during nursing or bottle-feeding.
In critical cases, these symptoms typically manifest within the first 24 to 48 hours or within the first week of life. Early identification allows for stabilization and transfer to a facility capable of performing neonatal cardiac surgery.
Strengthening the Healthcare Infrastructure and Public Education
Addressing the CHD crisis in Indonesia requires a multi-pronged approach involving government policy, healthcare provider training, and public education. The Indonesian Ministry of Health and organizations like IDAI are working toward decentralizing cardiac care. Currently, the concentration of pediatric cardiac services in Java creates a geographical barrier for families in Sumatra, Kalimantan, Papua, and other regions.
The role of primary healthcare providers, particularly midwives (bidan), is being re-evaluated. Since midwives attend a large percentage of births in Indonesia, equipping them with the knowledge to perform pulse oximetry and recognize early clinical signs of CHD is a high-priority strategy. Dr. Rizky points out that digital platforms are playing an increasing role in this educational push. The YouTube channel "Sehatkan Jantung Anak Indonesia" serves as a resource for both parents and healthcare workers to learn about screening protocols and the importance of early detection.
Furthermore, the economic implications of CHD cannot be ignored. The cost of cardiac surgery and long-term care is substantial. While the national health insurance program (BPJS Kesehatan) covers many of these procedures, the indirect costs—such as travel to specialized centers and loss of income for parents—can be devastating. By shifting the focus toward prevention (through Rubella vaccination and prenatal nutrition) and early detection (which can lead to less invasive and more successful early interventions), the overall burden on the healthcare system and families can be reduced.
Conclusion: A Call for Proactive Prenatal and Postnatal Care
The fight against Congenital Heart Disease in Indonesia is a race against time and a battle for better resources. While the medical community continues to investigate the genetic and environmental nuances of heart development, the current focus remains on what can be controlled.
Preventive measures, such as ensuring all women of childbearing age are vaccinated against Rubella and encouraging the consistent intake of folic acid and nutritious foods during pregnancy, are the first line of defense. Once a child is born, the implementation of universal pulse oximetry screening could save thousands of lives by identifying critical defects before a crisis occurs.
As Dr. Rizky Adriansyah and his colleagues at IDAI advocate for better facilities and increased awareness, the message to the public is clear: CHD is a serious and prevalent condition, but it is not a silent one. Through vigilant prenatal care and proactive postnatal screening, the goal of reducing neonatal mortality and ensuring a healthier future for Indonesia’s children is within reach. The integration of simple technology, expert medical training, and community-wide education forms the blueprint for a national strategy to protect the hearts of the next generation.
